To promote the clinical translation and innovation of ophthalmology and vision science in China, and to integrate with the global industry e...查看详情
CFDA said it has further simplified the examination and approval procedures for imported drugs. Under the reform measures, new drugs for rare and fatal diseases are able to directly submit their research filings overseas to the Chinese drug authorities for a quick pass.查看详情
Digital health tools have vast potential improve our ability to accurately diagnose and treat disease. And to enhance the delivery of health...查看详情
RIMONCI IN THE NEWS
6Over6, an Israeli startup that has developed an app that lets users perform their own eye-vision test for contact lenses or glasses, says it has raised $11 million from investors led by the Chinese venture capital fund Rimonci Capital.
Vision China 2017, aka, International Forum on the Innovation and Development of Vision Health was successfully held in Hangzhou, China from July 27 to July 30, 2017. Within this three and half days conference, there were over 3000 participants from China, America, Britain, Australia, Israel, Singapore, Korea, Taiwan, Hongkong, which includes top ophthalmologists, optometrists, entrepreneurs, investors and all the industry players.